Search for Clinical Trial Results

Sponsored By

Homologous Wasting Disease - 25 Studies Found

Status Study
Completed Study Name: Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Date: 2003-02-05
Interventions:
  • Biological: Daclizumab Other N
Completed Study Name: Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Date: 2002-03-08
Interventions:
  • Drug: cyclosporine
  • Drug: hydroxychloroquin
Completed Study Name: Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract
Condition: Graft Versus Host Disease
Date: 2003-03-06
Interventions: Drug: beclomethasone dipropionate
Not yet recruiting Study Name: A Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
Condition: Graft vs. Host Disease
Date: 2016-08-11
Interventions:
  • Drug: Obinutuzumab B cell depl
Recruiting Study Name: Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract
Condition: Graft Versus Host Disease
Date: 2014-06-25
Interventions:
  • Drug: Natalizumab Other Name:

Completed Study Name: Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Date: 2002-08-05
Interventions:
  • Drug: beclomethasone dipropionate
  • Drug: me
Active, not recruiting Study Name: Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Condition: Graft vs. Host Disease
Date: 2012-10-22
Interventions:
  • Drug: Ustekinumab One subcutan
Recruiting Study Name: Topical Vitamin D in Acute Graft Versus Host Disease of the Skin
Condition: Graft Vs Host Disease
Date: 2017-03-23
Interventions: Dietary Supplement: Calcipotriene Topical vitamin D cream will be applied to affected areas of the skin.
Completed Study Name: Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT
Condition: Graft-Versus-Host Disease
Date: 2014-05-13
Interventions: Drug: Cyclosporine Use of topical cyclosporine (one drop of cyclosporine in each eye, twice a day for 12
Terminated Study Name: A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
Condition: Graft Versus Host Disease
Date: 2010-02-08
Interventions: Drug: Rituximab Rituximab 375 mg/m2 IV weekly X 4 doses + Prednisone 1 mg/kg/d
Next >>>